Hospitals sue to require drug pricing transparency in 340B | Healthcare Dive

Dive Brief:

  • Four industry associations sued HHS for the second time over its delay in adding regulations to the 340B Drug Pricing Program that would require pricing transparency for drug manufacturers and penalties for overcharging hospitals covered under the program.
  • Filed by the American Hospital Association, the Association of American Medical Colleges, America’s Essential Hospitals and 340B Health, the lawsuit asks the court to declare the department’s delay in implementing those regulations unlawful. The groups are also asking the court to order HHS to make the final rule that implements those regulations effective in 30 days.
  • HHS delayed putting in place ceiling prices for the fifth time in June. Secretary Alex Azar has defended these delays by signaling the implementations will be rolled into the administration’s larger plan to cut drug costs.

Read complete article here:

Hospitals sue to require drug pricing transparency in 340B | Healthcare Dive.